Page 367 - COMMUNITY PHARMACY PRACTICE
P. 367
2018 Diabetes Canada CPG – Chapter 17. Weight Managemen
Weight Effect con
Selecting Diabet
Weight Gain
Insulin
TZDs
Sulfonylureas
Meglitinides
NALWeight Neutral or Decrease Weight
PERSOMetformin
α-Glucosidase inhibitors
DPP-4 inhibitors
GLP-1 receptor agonists
SGLT2 inhibitors
Table 1 of Pharmacologic Glycemic Management of Type 2 D
